Skip to main content
Drug Resistant EpilepsyBrain and nervesDevice

What this study is

Drug-resistant epilepsy represents roughly 40% of people with epilepsy. It is very challenging to stop seizures in this condition, and the treatment options are limited. This study aims to investigate a new treatment that involves using infra-red light. In animals, this treatment has shown promise as a possible way to reduce seizures, but it has not been tested in humans for this. The investigators are interested to know if it can reduce seizures, and how comfortable it is to be treated with this therapy.

What's being tested

  • photobiomodulation

    Intervention · DEVICE

    a hat with infrared lights will be worn for 30 minutes daily for 6 months

Study details

Official title
An Open Label Pilot Study of Infrared Photobiomodulation in Humans With Epilepsy
Sponsor
Beth Israel Deaconess Medical Center
Conditions
Drug Resistant Epilepsy
Enrolling
13 people
Starts
2025-11-25
Est. completion
2027-09-25
Design
Open-label, single group
Record
View on ClinicalTrials.gov ↗